Partnering in the Global Generics Industry 2009: A guide to companies

Date: October 22, 2009
Pages: 526
Price:
US$ 1,040.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P57DF881443EN
Leaflet:

Download PDF Leaflet

Partnering in the Global Generics Industry 2009: A guide to companies
Identify merger, acquisition and partner candidates in the rapidly changing global generics market…
...
Consolidation and collaboration runs throughout the generic industry. Here’s just a taste of the acquisitions, controlling investments and deals in 2008/09...

Ascent to acquire Green Cross Pharma of Singapore
Aurobindo Pharma and Pfizer to commercialise off-patent products
Biocon and Mylan enter generic biologics development
Sanitas acquires Homeofarm
Hovione acquires Pfizer plant in Ireland
Adcock Ingram tried and failed to acquire Cipla Medpro
Hi-Tech Pharmacal acquires ECR Pharmaceuticals
URL Pharma acquires PharmPro manufacturing facility and equipment

Strategic partnering

In addition to outright purchase, strategic partnering or the acquisition of specific drug assets is on the rise as companies seek to bring lower costs and focus to their portfolios. With business cycles growing shorter and shorter, market entry is quicker and more reliable through acquisition and partnering.

The fundamental market drivers are sound

In addition to ongoing expansion, there are other drivers which are causing generic companies to consider the future:

Over the next 5 years over 40 blockbuster pharmaceutical products such as Lipitor, Cozaar, Effexor, Plavix, and Cymbalta will be losing patent protection.

The number of biologics coming into the remit of generic companies is increasing, raising interest in companies with biosimilars production capability.

The branded industry’s response

The branded industry continues to vigorously protect its IP and maximise the lifetime value of its products. While legal initiatives will remain a key weapon there will also be commercial responses such as issuing early branded generics, collaborative working with a limited number of generic producers, new formulations or combination products.

Identify new business opportunities and assess risk

For everyone needing to evaluate the generic industry’s competitive landscape, this thoroughly-researched and expanded 2nd edition of Partnering in the Global Generics Industry 2009: A guide to companies (published October 2009) is essential reading. In over 460 pages this new, completely revised edition references 170 generic companies operating in 40 markets around the world.
INTRODUCTION

ARGENTINA

Osmotica Pharmaceutical
  Background
  Products
  Contact Details

AUSTRALIA

Ascent Pharmahealth
  Background
  Products
  Financials
  Major Developments
  Contact Details
Australian Pharmaceutical Industries
  Background
  Financials
  Major Developments
  Contact Details
Hamilton Laboratories
  Background
  Products
  Contact Details
Sigma Pharmaceuticals
  Background
  Products
  Financials
  Major Developments
  Contact Details

AUSTRIA

Ebewe Pharma
  Background
  Products
  Financials
  Major Developments
  Contact Details

BANGLADESH

Beximco Pharmaceuticals
  Background
  Products
  Financials
  Major Developments
  Contact Details

BRAZIL

Aché
  Background
  Products
  Financials
  Major Developments
  Contact Details
Americano
  Background
  Products
  Financials
  Contact Details
Biolab
  Background
  Contact Details
Cimed
  Background
  Products
  Financials
  Contact Details
Cristália
  Background
  Products
  Contact Details
EMS-Sigma
  Background
  Products
  Financials
  Contact Details
Eurofarma
  Background
  Contact Details
LAFEPE
  Background
  Products
  Contact Details
Libbs Farmacêutica
  Background
  Financials
  Major Developments
  Contact Details
Medley
  Background
  Products
  Financials
  Major Developments
  Contact Details
Prati-Donaduzzi
  Background
  Products
  Financials
  Contact Details

BULGARIA

Sopharma
  Background
  Products
  Financials
  Contact Details
Unipharm
  Background
  Contact Details

CANADA

Labopharm
  Background
  Products
  Financials
  Major Developments
  Contact Details
Orbus Pharma
  Background
  Products
  Financials
  Major Developments
  Contact Details
Pharmascience
  Background
  Products
  Major Developments
  Contact Details

CHILE

Andrómaco
  Background
  Products
  Financials
  Major Developments
  Contact Details
Bestpharma
  Background
  Products
  Contact Details
Biosano
  Background
  Products
  Financials
  Contact Details
Maver
  Background
  Contact Details
Mintlab
  Background
  Contact Details

CHINA

China Pharma Holdings
  Background
  Products
  Financials
  Contact Details
Simcere Pharmaceutical Group
  Background
  Products
  Financials
  Major Developments
  Contact Details

COLOMBIA

Ecar
  Background
  Contact Details
Genfar
  Background
  Contact Details
La Santé
  Background
  Contact Details
Lafrancol
  Background
  Contact Details

CROATIA

Belupo
  Background
  Products
  Contact Details

DENMARK

Alternova
  Background
  Products
  Contact Details
Orifarm
  Background
  Products
  Contact Details

EGYPT

EIPICo
  Background
  Contact Details

FRANCE

Biogaran
  Background
  Contact Details

INDIA

Alembic
  Background
  Products
  Financials
  Major Developments
  Contact Details
Alkem Laboratories
  Background
  Products
  Major Developments
  Contact Details
Aurobindo Pharma
  Background
  Products
  Financials
  Major Developments
  Contact Details
Biocon
  Background
  Products
  Financials
  Major Developments
  Contact Details
Emcure Pharmaceuticals
  Background
  Major Developments
  Contact Details
Gland Pharma
  Background
  Products
  Contact Details
Glenmark Pharmaceuticals
  Background
  Products
  Financials
  Major Developments
  Contact Details
Hetero Drugs
  Background
  Products
  Contact Details
Indoco Remedies
  Background
  Products
  Financials
  Major Developments
  Contact Details
JB Chemicals & Pharmaceuticals
  Background
  Products
  Financials
  Major Developments
  Contact Details
Jubilant Organosys
  Background
  Products
  Financials
  Major Developments
  Contact Details
Lupin Laboratories
  Background
  Products
  Financials
  Major Developments
  Contact Details
Natco Pharma
  Background
  Products
  Financials
  Major Developments
  Contact Details
Orchid Chemicals & Pharmaceuticals
  Background
  Products
  Financials
  Major Developments
  Contact Details
Strides Arcolab
  Background
  Products
  Financials
  Major Developments
  Contact Details
Sun Pharmaceutical Industries
  Background
  Products
  Financials
  Major Developments
  Contact Details
Torrent Pharmaceuticals
  Background
  Products
  Financials
  Major Developments
  Contact Details
USV
  Background
  Products
  Contact Details

INDONESIA

Kimia
  Background
  Contact Details

IRELAND

Consilient Health
  Background
  Products
  Contact Details
Reliance GeneMedix
  Background
  Products
  Financials
  Major Developments
  Contact Details

ISRAEL

Dexcel
  Background
  Products
  Major Developments
  Contact Details
Taro Pharmaceutical Industries
  Background
  Products
  Financials
  Major Developments
  Contact Details

ITALY

Eurand
  Background
  Products
  Contact Details

JAPAN

Nichi-iko Pharmaceutical
  Background
  Financials
  Major Developments
  Contact Details
Towa Pharmaceutical
  Background
  Products
  Financials
  Major Developments
  Contact Details

JORDAN

Hikma
  Background
  Products
  Financials
  Major Developments
  Contact Details

KENYA

Regal Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details

LATVIA

Grindeks
  Background
  Products
  Financials
  Major Developments
  Contact Details

LITHUANIA

Sanitas
  Background
  Products
  Financials
  Major Developments
  Contact Details

MALAYSIA

CCM Pharmaceuticals
  Background
  Products
  Financials
  Major Developments
  Contact Details
Inno Biologics
  Background
  Products
  Contact Details

MEXICO

Laboratorios Kendrick
  Background
  Contact Details
Laboratorios Silanes
  Background
  Contact Details

PAKISTAN

CCL
  Background
  Contact Details
Dr Raza Pharma
  Background
  Contact Details
Epla Labs
  Background
  Products
  Contact Details
Highnoon Laboratories
  Background
  Products
  Financials
  Contact Details

PERU

Farmindustria
  Background
  Contact Details
Induquímica
  Background
  Products
  Contact Details
Infarmasa
  Background
  Financials
  Contact Details

PORTUGAL

Hovione FarmaCiencia
  Background
  Products
  Financials
  Major Developments
  Contact Details

ROMANIA

Antibiotice
  Background
  Products
  Financials
  Contact Details
Europharm
  Background
  Contact Details

RUSSIA

Akrikhin
  Background
  Products
  Contact Details
Bryntsalov A
  Background
  Contact Details
Erka Farm
  Background
Farmacon
  Background
  Contact Details
Pharmstandard
  Background
  Products
  Financials
  Major Developments
  Contact Details
Veropharm
  Background
  Financials
  Contact Details

SAUDI ARABIA

Tabuk Pharmaceutical Manufacturing
  Background
  Contact Details

SLOVAKIA

Biotika
  Background
  Financials
  Contact Details

SOUTH AFRICA

Adcock Ingram
  Background
  Products
  Major Developments
  Contact Details
Cipla Medpro
  Background
  Products
  Financials
  Major Developments
  Contact Details

SPAIN

Combino Pharm
  Background
  Products
  Major Developments
  Contact Details
Invent Farma Group
  Background
  Products
  Major Developments
  Contact Details
Laboratorios Cinfa
  Background
  Products
  Major Developments
  Contact Details

SWITZERLAND

Acino Pharma
  Background
  Financials
  Contact Details
Azad
  Background
  Products
  Major Developments
  Contact Details
Helvepharm
  Background
  Contact Details
Mepha Pharma
  Background
  Financials
  Contact Details
Spirig
  Background
  Products
  Financials
  Contact Details
Streuli
  Background
  Financials
  Contact Details

TURKEY

Abdi Ibrahim
  Background
  Products
  Major Developments
  Contact Details
Bilim Pharmaceuticals
  Background
  Products
  Contact Details
EastPharma
  Background
  Products
  Financials
  Contact Details
Mustafa Nevzat Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details

UK

Goldshield Group
  Background
  Products
  Financials
  Major Developments
  Contact Details
Kent Pharmaceuticals
  Background
  Major Developments
  Contact Details
ProStrakan
  Background
  Products
  Financials
  Major Developments
  Contact Details
Rosemont Pharmaceutical
  Background
  Products
  Major Developments
  Contact Details

USA

APP Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Akorn
  Background
  Products
  Financials
  Major Developments
  Contact Details
Amneal Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Amphastar Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Anchen Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Banner Pharmacaps
  Background
  Products
  Major Developments
  Contact Details
Bedford Laboratories
  Background
  Products
  Major Developments
  Contact Details
Bio-Nucleonics
  Background
  Products
  Contact Details
Boca Pharmacal
  Background
  Products
  Contact Details
Caraco Pharmaceutical Laboratories
  Background
  Products
  Financials
  Major Developments
  Contact Details
Carolina Medical Products Company
  Background
  Products
  Contact Details
Cedar Pharmaceuticals
  Background
  Products
  Contact Details
Cephazone Pharma
  Background
  Products
  Contact Details
CorePharma
  Background
  Products
  Major Developments
  Contact Details
Cypress Pharmaceutical
  Background
  Products
  Major Developments
  Contact Details
Ferndale Laboratories
  Background
  Products
  Major Developments
  Contact Details
Fleming Pharmaceuticals
  Background
  Products
  Contact Details
Fougera
  Background
  Products
  Major Developments
  Contact Details
G&W Laboratories
  Background
  Products
  Contact Details
GeneraMedix
  Background
  Products
  Major Developments
  Contact Details
Glades Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
GC Hanford Manufacturing
  Background
  Products
  Contact Details
Harmony Labs
  Background
  Products
  Contact Details
Heritage Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Hi-Tech Pharmacal
  Background
  Products
  Financials
  Major Developments
  Contact Details
Impax Laboratories
  Background
  Products
  Financials
  Major Developments
  Contact Details
Indicus Pharmaceuticals
  Background
  Products
  Contact Details
InvaGen Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Kremers-Urban (KUDCo)
  Background
  Products
  Major Developments
  Contact Details
KV Pharmaceutical
  Background
  Products
  Financials
  Major Developments
  Contact Details
KVK-Tech
  Background
  Products
  Contact Details
Luitpold Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Lyne Laboratories
  Background
  Products
  Contact Details
Mallinckrodt
  Background
  Products
  Major Developments
  Contact Details
Mikart
  Background
  Products
  Contact Details
Neil Laboratories
  Background
  Products
  Contact Details
Nephron Pharmaceuticals
  Background
  Products
  Contact Details
Paddock Laboratories
  Background
  Products
  Major Developments
  Contact Details
Parenta Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Pharmaceutical Associates
  Background
  Products
  Contact Details
PharmaForce
  Background
  Products
  Contact Details
Prasco
  Background
  Products
  Major Developments
  Contact Details
Prometheus Laboratories
  Background
  Products
  Contact Details
Roxane Laboratories
  Background
  Products
  Major Developments
  Contact Details
RxElite Holdings
  Background
  Products
  Major Developments
  Contact Details
Silarx Pharmaceuticals
  Background
  Products
  Contact Details
Spear Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
Stiefel
  Background
  Products
  Major Developments
  Contact Details
SuperGen
  Background
  Products
  Financials
  Major Developments
  Contact Details
Three Rivers Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details
URL Pharma
  Background
  Products
  Major Developments
  Contact Details
Upsher-Smith Laboratories
  Background
  Products
  Major Developments
  Contact Details
Vista Pharmaceuticals
  Background
  Products
  Contact Details
VistaPharm
  Background
  Products
  Contact Details
X-GEN Pharmaceuticals
  Background
  Products
  Major Developments
  Contact Details

VENEZUELA

Calox Internacional
  Background
  Contact Details
Cofasa
  Background
  Contact Details
Kimiceg
  Background
  Contact Details
Leti
  Background
  Contact Details
Meyer
  Background
  Contact Details

INDEX OF TABLES

Companies in the report by country of origin
Osmotica Pharmaceutical ANDA Approvals, 2002-09
Ascent Pharmahealth: Reported Half-Year Results, 2007 - 2008 (A$000s)
Australian Pharmaceutical Industries: Consoliated Results, FY2006 – FY2008 (A$000s) . 15
Sigma Pharmaceuticals: Financial Results, 2005 - 2009 (A$ millions)
Ebewe Pharma ANDA Approvals, 2002-09
Beximco Pharmaceuticals: 2002 – 2008 Results (BDT millions)
Cimed: Sales, 2004 - 2007
Cristália‟s Business Units, 2006
Cristália‟s International Representatives, 2006
EMS: Generics Registrations & Marketing Authorisations by Division, 2006
EMS: Sales by Division, 2006
LAFEPE: Product Lines, 2007
Libbs Farmacêutica: Pharmaceutical Sales, 2000 - 2006
Medley: International Agreements, 1992 - 2005
Medley: Sales, 2006 - 2007
Sopharma: Financial Data, 1999 – 2007 (Leva 000s)
Labopharm: Financial Results, 2004 – 2008 (C$000s)
Orbus Pharma: Rx Development Complete
Orbus Pharma: Rx Under Development
Orbus Pharma: Financial Results, 2003 – 2008 (C$000s)
Orbus Pharma: Financial Results by Geography, 2007 – 2008 (C$000s)
Andrómaco: Financial Results, 2000 - 2007
Biosano: Product Portfolio, 2008
Simcere Pharmaceutical Group: Financial Results, 2004 – 2008 (RMB000s)
Alembic: Financial Results, 2003 – 2009 (Rs millions)
Aurobindo Pharma ANDA Approvals, 2002-09
Aurobindo Pharma: Financial Results, 2004 – 2008 (Rs millions)
Biocon: Financial Results, 2004 – 2009 (Rs millions)
Gland Pharma ANDA Approvals, 2002-09
Glenmark Pharmaceuticals / Glenmark Generics ANDA Approvals, 2002-09
Glenmark Pharmaceuticals: Consolidated Financial Results (Rs millions)
Glenmark Pharmaceuticals: Consolidated Financial Results by Business (Rs millions)
Hetero Drugs ANDA Approvals, 2002-09
Indoco Remedies: Financial Results (Rs millions)
Unique Pharmaceutical Laboratories ANDA Approvals, 2002-09
JB Chemicals & Pharmaceuticals: Financial Results, FY2004-5 – FY2008-9 (Rs millions)143
Trigen Laboratories / Cadista Pharmaceuticals / Jubilant Pharmaceuticals ANDA Approvals, 2002-09
Jubilant Organosys: Standalone Financial Results, FY2008 – FY2009 (Rs millions)
Lupin Laboratories ANDA Approvals, 2002-09
Lupin Laboratories: Consolidated Financial Results, FY2004 – 2009 (Rs millions)
Natco Pharma ANDA Approvals, 2002-09
Natco Pharma: Standalone Financial Results, 2004 – 2008 (Rs millions)
Orchid Healthcare ANDA Approvals, 2002-09
Orchid Chemicals & Pharmaceuticals: FY2004-5 – FY2007-8 results (Rs millions)
Akorn-Strides ANDA Approvals, 2002-09
Strides Arcolab: Consolidated Financial Results, 2005 – 2008 (Rs millions)
Sun Pharmaceutical Laboratories ANDA Approvals, 2002-09
Sun Pharmaceutical Industries: Financial Results, 2005 – 2008 (Rs millions)
Torrent Pharmaceuticals ANDA Approvals, 2002-09
Torrent Pharmaceuticals: Financial Results, 2007 – 2008 (Rs millions)
Reliance GeneMedix: Financial Results (£000s)
Dexcel ANDA Approvals, 2002-09
Taro Pharmaceutical Industries ANDA Approvals, 2002-09
Taro Pharmaceutical Industries: Financial Results, 2000 – 2005 (US$000s)
Taro Pharmaceutical Industries: Sales by Location, 2002 – 2005 (US$000s)
Taro Pharmaceutical Industries: Estimated Results for Year Ended 31st December 2008 (US$000s)
Taro Pharmaceutical Industries: Restatements for 2004 and 2005 (US$000s)
Eurand ANDA Approvals, 2002-09
Nichi-Iko: Medium Term Business Plan Goals (¥ millions)
Towa Pharmaceutical: Financial Results, FY2004 – FY2008 (¥ millions)
Hikma: 2008 filings
Hikma Pharmaceuticals ANDA Approvals, 2002-09
West-Ward ANDA Approvals, 2002-09
Hikma: Financial Results, 2006 - 2008 (US$000s)
Hikma: Financial Results by Region, 2006 - 2008 (US$000s)
Grindeks Group: Financial Results, 2004 – 2008 (LVL000s)
Grindeks Group: Sales by Location, 2004 – 2008 (LVL000s)
Sanitas: Group Financial Results, 2002 – 2008 (LTL000s)
Sanitas: Selected Financial Results by Region, 2004 – 2008 (LTL000s)
Antibiotice: Financial Results, 2002 – 2007
Pharmstandard: Production by Facility, 2007
Pharmstandard: Financial Results, 2004 – 2008 (R millions)
Pharmstandard: Pharmaceutical Sales, 2006 – 2008
Cipla Medpro: Group Financial Results (R000s)
EastPharma: Financial Results, 2006 and 2009 (US$000s)
Goldshield: Financial Results, 2003 – 2009 (£000s)
Goldshield: Sales by Region, 2006 – 2009 (£000s)
Goldshield: Selected Sales by Segment, 2006 – 2009 (£000s)
ProStrakan: Financial Results, 2002 – 2008 (£ millions)
ProStrakan: Selected Financial Results by Destination, 2002 – 2008 (£ millions)
American Pharmaceutical Partners ANDA Approvals, 2002-06
Abraxis ANDA Approvals, 2006-08
APP Pharmaceuticals ANDA Approvals, 2008-2009
Akorn ANDA Approvals, 2002-09
Akorn-Strides ANDA Approvals, 2002-09
Akorn: Financial Results, 2002 – 2008 (US$000s)
Amneal Pharmaceuticals ANDA Approvals, 2006-09
Akyma Pharmaceuticals ANDA Approvals, 2002-09
Interpharm ANDA Approvals, 2002-09
Amphastar Pharmaceuticals ANDA Approvals, 2002-09
International Medication Systems ANDA Approvals, 2002-09
Anchen Pharmaceuticals ANDA Approvals, 2002-09
Banner Pharmacaps ANDA Approvals, 2002-09
Bedford Laboratories ANDA Approvals, 2002-09
Ben Venue Laboratories ANDA Approvals, 2002-09
Bio-Nucleonics ANDA Approvals, 2002-09
Boca Pharmacal ANDA Approvals, 2002-09
Caraco Pharmaceutical Laboratories ANDA Approvals, 2002-09
Caraco Pharmaceutical Laboratories: Financial Results, FY2005 – FY2009 (US$000s)
Carolina Medical Products ANDA Approvals, 2002-09
Cedar Pharmaceuticals ANDA Approvals, 2002-09
Cephazone Pharma ANDA Approvals, 2002-09
CorePharma ANDA Approvals, 2002-09
Cypress Pharmaceutical ANDA Approvals, 2002-09
Ferndale Laboratories ANDA Approvals, 2002-09
Fleming & Company Pharmaceuticals ANDA Approvals, 2002-09
Altana ANDA Approvals, 2002-09
G&W Laboratories ANDA Approvals, 2002-09
GeneraMedix ANDA Approvals, 2002-09
Glades Pharmaceuticals ANDA Approvals, 2002-09
GC Hanford Manufacturing ANDA Approvals, 2002-09
Harmony Labs ANDA Approvals, 2002-09
Hi-Tech Pharmacal ANDA Approvals, 2002-09
Hi-Tech Pharmacal: FY2005 – FY2009 Results (US$ millions)
Impax Laboratories ANDA Approvals, 2002-09
Impax Laboratories: Financial Results, 2004 - 2008 (US$000s)
Indicus Pharmaceuticals ANDA Approvals, 2002-09
InvaGen Pharmaceuticals ANDA Approvals, 2002-09
KUDCo ANDA Approvals, 2002-09
KV Pharmaceuticals / Ethex ANDA Approvals, 2002-09
KV Pharmaceutical: Financial Results, 2002 – 2008 (US$ millions)
KVK-Tech ANDA Approvals, 2002-09
Luitpold Pharmaceuticals ANDA Approvals, 2002-09
Lyne Laboratories ANDA Approvals, 2002-09
Mallinckrodt ANDA Approvals, 2002-09
Mikart ANDA Approvals, 2002-09
Neil Laboratories ANDA Approvals, 2002-09
Nephron Pharmaceuticals ANDA Approvals, 2002-09
Paddock Laboratories ANDA Approvals, 2002-09
Parenta Pharmaceuticals ANDA Approvals, 2002-09
Pharmaceutical Associates ANDA Approvals, 2002-09
PharmaForce ANDA Approvals, 2002-09
Prometheus Laboratories ANDA Approvals, 2002-09
Roxane Laboratories ANDA Approvals, 2002-09
RxElite ANDA Approvals, 2002-09
Silarx Pharmaceuticals ANDA Approvals, 2002-09
Spear Pharmaceuticals ANDA Approvals, 2002-09
Stiefel ANDA Approvals, 2002-09
SuperGen ANDA Approvals, 2002-09
SuperGen: Financial Results, 2004 – 2008 (US$ millions)
Three Rivers ANDA Approvals, 2002-09
Mutual Pharmaceutical Company ANDA Approvals, 2002-09
Upsher-Smith Laboratories ANDA Approvals, 2002-09
Vista Pharmaceuticals ANDA Approvals, 2002-09
VistaPharm ANDA Approvals, 2002-09
X-GEN Pharmaceuticals ANDA Approvals, 2002-09
Skip to top


Ask Your Question

Partnering in the Global Generics Industry 2009: A guide to companies
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: